Chronic exposure to nicotine does not prevent neurocognitive decline after cardiac surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 17, Issue 3, 2003, Pages 341-345

  Djaiani, George N ^a   Phillips Bute, Barbara ^b   Blumenthal, James A ^b   Newman, Mark F ^b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b NONE

Author keywords

Cognitive dysfunction; Coronary artery bypass graft surgery; Smoking

Indexed keywords

CREATININE; NICOTINE;

ADULT; AGE; AGED; ANESTHESIA; ARTICLE; CIGARETTE SMOKING; COGNITIVE DEFECT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; EDUCATION; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; KIDNEY DISEASE; LIVER DISEASE; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEUROLOGIC DISEASE; OPERATION DURATION; PREDICTION; PREOPERATIVE EVALUATION; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; READING; RETROSPECTIVE STUDY; REVIEW; SCORING SYSTEM; STROKE; SURGICAL TECHNIQUE; TRANSIENT ISCHEMIC ATTACK; UNIVERSITY HOSPITAL;

EID: 0038798781     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(03)00047-8     Document Type: Article

References (33)

1. Newman MF, Croughwell ND, Blumenthal JA, et al: Predictors of cognitive decline after cardiac operation. Ann Thorac Surg 59:1326-1330, 1995
2. Blumenthal JA, Mahanna EP, Madden DJ, et al: Methodological issues in the assessment of neuropsychological function after cardiac surgery. Ann Thorac Surg 59:1345-1350, 1995
3. Murkin JM, Baird DL, Martzke JS, et al: Long-term neurological and neuropsychological outcome 3 years after coronary artery bypass surgery. Anesth Analg 82:S328, 1996
4. Newman MF, Kirchner JL, Phillips-Bute B, et al: Longitudinal assessment of neurocognitive function after coronary artery bypass surgery. N Engl J Med 344:395-402, 2001
5. Perry E: Cholinergic mechanisms and cognitive decline. Eur J Anaesthesiol 15:768-773, 1998
6. Court JA, Perry EK: CNS nicotinic receptors therapeutic target in neurodegeneration. CNS Drugs 2:216-233, 1994
7. Sarter M, Bruno JP: Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. Brain Res Brain Res Rev 23:28-46, 1997
8. Everitt BJ, Robbins TW: Central cholinergic systems and cognition. Annu Rev Psychol 48:649-684, 1997
9. Newman MF, Croughwell ND, Blumenthal JA, et al: Effect of aging on cerebral autoregulation during cardiopulmonary bypass. Association with postoperative cognitive dysfunction. Circulation 90:11243-249, 1994
10. Stanley TO, Mackensen GB, Grocott HP, et al: The impact of postoperative atrial fibrillation on neurocognitive outcome after coronary artery bypass graft surgery. Anesth Analg 94:290-295, 2002
11. Murkin JM, Newman SP, Stump DA, et al: Statement of consensus on assessment of neurobehavioral outcomes after cardiac surgery. Ann Thorac Surg 59:1289-1295, 1995
12. Randt C, Brown E: Administration Manual: Randt Memory Test. New York, NY, Life Sciences Associates, 1983
13. Wechsler D: The Wechsler Adult Intelligence Scale: Revised (manual). San Antonio, TX, The Psychological Corporation, 1981
14. Wechsler D: Wechsler Memory Scale: Revised (manual). San Antonio, TX, The Psychological Corporation, 1987
15. Reitan RM, Davidson LA: Clinical Neuropsychology: Current Status and Applications. New York, NY, Winston/Wiley, 1974
16. Rey A: L'examen Clinique en Psychologie. Paris, France, Presses Universitaires de France, 1964
17. Burker EJ, Blumenthal JA, Feldman M, et al: The Mini Mental State Exam as a predictor of neuropsychological functioning after cardiac surgery. Int J Psychiatry Med 25:263-276, 1995
18. Vingerhoets G, Van Nooten G, Vermassen F, et al: Short-term and long-term neuropsychological consequences of cardiac surgery with extracorporeal circulation. Eur J Cardiothorac Surg 11:424-431, 1977
19. Smith MH, Wagenknecht LE, Legault C, et al: Age and other risk factors for neuropsychologic decline in patients undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 14:428-432, 2000
20. Wareing TH, Davila-Roman VG, Daily BB, et al: Strategy for the reduction of stroke incidence in cardiac surgical patients. Ann Thorac Surg 55:1400-1407, 1993
21. Menotti A, Keys A, Blackburn H, et al: Comparison of multivariate predictive power of major risk factors for coronary heart diseases in different countries: Results from eight nations of the Seven Countries Study, 25-year follow-up. J Cardiovasc Risk 3:69-75, 1996
22. D'Agostino RB, Russell MW, Huse DM, et al: Primary and subsequent coronary risk appraisal: New results from the Framingham study. Am Heart J 139:272-281, 2000
23. Kaarisalo MM, Immonen-Raiha P, Marttila RJ, et al: Long-term predictors of stroke in a cohort of people aged 70 years. Arch Gerontol Geriatr 31:43-53, 2000
24. Allen SJ, MacGowan SH, Tyler S, et al: Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype. Neurosci Lett 239:33-36, 1997
25. Slooter AJ, Tang MX, van Duijn CM, et al: Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation. JAMA 277:818-821, 1997
26. Tardiff BE, Newman MF, Saunders AM, et al: Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center. Ann Thorac Surg 64:715-720, 1997
27. Perkins KA, Gerlach D, Broge M, et al: Quitting cigarette smoking produces minimal loss of chronic tolerance to nicotine. Psychopharmacology (Berl) 158:7-17, 2001
28. Meyer EL, Gahring LC, Rogers SW: Nicotine preconditioning antagonizes activity-dependent caspase proteolysis of a glutamate receptor. J Biol Chem 277:10869-10875, 2002
29. Foulds J, Stapleton JA, Bell N, et al: Mood and physiological effects of subcutaneous nicotine in smokers and never-smokers. Drug Alcohol Depend 44:105-115, 1997
30. Perkins KA, Grobe JE, Fonte C, et al: Chronic and acute tolerance to subjective, behavioral and cardiovascular effects of nicotine in humans. J Pharmacol Exp Ther 270:628-638, 1994
31. Foulds J, Swettenham J, Bell N, et al: Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers. Psychopharmacology 127:31-38, 1996
32. Newhouse PA, Potter A, Corwin J, et al: Acute nicotinic blockade produces cognitive impairment in normal humans. Psychopharmacology 108:480-484, 1992
33. Newhouse PA, Potter A, Corwin J, et al: Age-related effects of the nicotinic antagonist mecamylamine on cognition and behavior. Neuropsychopharmacology 10:93-107, 1994